Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect

Early Human Development

Volumn 89, Issue 8, 2013, Pages 519-524

  Hanley, Gillian E ^a,b   Brain, Ursula ^a,b   Oberlander, Tim F ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Infant outcomes; Neurodevelopment; Serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADAPTIVE BEHAVIOR; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EMOTION; FEMALE; HUMAN; INFANT; MOOD; OUTCOME ASSESSMENT; PRENATAL EXPOSURE; PUERPERAL DEPRESSION; SMOKING; SOCIAL ASPECT;

ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CHILD DEVELOPMENT; DEPRESSION; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 84879839858     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.12.012     Document Type: Article

References (60)

1. Casper R.C., Fleisher B.E., Lee-Ancajas J.C., Gilles A., Gaylor E., DeBattista A., et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003, 142:402-407.
2. Pedersen L.H., Henriksen T.B., Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19months of age. Pediatrics 2010, 125(3):e600-e608.
3. Mortensen J., Olsen J., Larsen H., Bendsen J., Obel C., Sørensen H. Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. Eur J Epidemiol 2003, 18(8):769-771.
4. Nulman I., Rovet J., Stewart D.E., Wolpin J., Gardner H.A., Theis J.G.W., et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997, 336(4):258-262.
5. Nulman I., Rovet J., Stewart D.E., Wolpin J., Pace-Asciak P., Shuhaiber S., et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002, 159(11):1889-1895.
6. Oberlander T.F., Eckstein G. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res 2002, 51(4):443-453.
7. Cooper W.O., Willy M.E., Pont S.J., Ray W.A. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007, 196(6):544.e1-544.e5.
8. Oberlander T.F., Warburton W., Misri S., Aghajanian J., Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006, 63(8):898-906.
9. Oberlander T., Gingrich J., Ansorge M. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharm Ther 2009, 86(6):672-677.
10. DiPietro J.A., Costigan K.A., Gurewitsch E.D. Fetal response to induced maternal stress. Early Hum Dev 2003, 74(2):125-138.
11. Tronick E.Z., Weinberg M.K. Depressed mothers and infants: failure to form dyadic states of consciousness. Postpartum depression and child development 1997, 54-81. Guilford Press, New York. L. Murray, P.J. Cooper (Eds.).
12. Allister L., Lester B.M., Carr S., Liu J. The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation. Dev Neuropsychol 2001, 20(3):639-651.
13. Monk C., Fifer W.P., Myers M.M., Sloan R.P., Trien L., Hurtado A. Maternal stress responses and anxiety during pregnancy: effects on fetal heart rate. Dev Psychobiol 2000, 36(1):67-77.
14. Glover V. Annual research review: prenatal stress and the origins of psychopathology: an evolutionary perspective. J Child Psychol Psychiatry 2011, 52(4):356-367.
15. Talge N.M., Neal C., Glover V. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry 2007, 48(3-4):245-261.
16. DiPietro J.A., Novak M.F.S.X., Costigan K.A., Atella L.D., Reusing S.P. Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev 2006, 77(3):573-587.
17. Bérard A., Ramos É., Rey É., Blais L., St-André M., Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 2007, 80(1):18-27.
18. Chambers C.D., Hernandez-Diaz S., Van Marter L.J., Werler M.M., Louik C., Jones K.L., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006, 354(6):579-587.
19. Hemels M.E.H., Einarson A., Koren G., Lanctot K.L., Einarson T.R. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 2005, 39(5):803-809.
20. Nakhai-Pour H.R., Broy P., Berard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 2010, 182(10):1031-1037.
21. Pedersen L.H., Henriksen T.B., Vestergaard M., Olsen J., Bech B.H. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009, 339:b3569-b3575.
22. Wurst K.E., Poole C., Ephross S.A., Olshan A.F. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol 2010, 88(3):159-170.
23. Homberg J.R., Schubert D., Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci 2010, 31(2):60-65.
24. Lisboa S.F.S., Oliveira P.E., Costa L.C., Venâncio E.J., Moreira E.G. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 2007, 80(1):49-56.
25. Bairy K., Madhyastha S., Ashok K., Bairy I., Malini S. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2007, 79(1):1-11.
26. Oberlander T.F., Grunau R.E., Fitzgerald C., Papsdorf M., Rurak D., Riggs W. Pain reactivity in 2-month-old infants after prenatal and postnatal selective serotonin reuptake inhibitor medication exposure. Pediatrics 2005, 115(2):411-425.
27. Misri S., Reebye P., Kendrick K., Carter D., Ryan D., Grunau R.E., et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry 2006, 163(6):1026-1032.
28. Klinger G., Frankenthal D., Merlob P., et al. Is selective serotonin reuptake inhibitor induced neonatal abstinence syndrome associated with adverse long-term outcome?. J Perinatol 2011, 31:615-620.
29. Galbally M., Lewis A.J., Buist A. Developmental outcomes in children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry 2011, 45:393-399.
30. Casper R.C., Gilles A., Fleisher B.E., Baran J., Enns G., Lazzeroni L.C. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology 2011, 217:211-219.
31. Warburton W., Hertzman C., Oberlander T. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand 2010, 121(6):471-479.
32. Yonkers K.A., Gotman N., Smith M.V., Forray A., Belanger K., Brunetto W.L., et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?. Epidemiology 2011, 22(6):848-854.
33. Feldman R., Eidelman A.I. Maternal postpartum behavior and the emergence of infant-mother and infant-father synchrony in preterm and full-term infants: the role of neonatal vagal tone. Dev Psychobiol 2007, 49(3):290-302.
34. MacDonald K. Warmth as a developmental construct: an evolutionary analysis. Child Dev 1992, 63(4):753-773.
35. Treyvaud K., Anderson V.A., Howard K., Bear M., Hunt R.W., Doyle L.W., et al. Parenting behavior is associated with the early neurobehavioral development of very preterm children. Pediatrics 2009, 123(2):555-561.
36. Bernier A., Carlson S.M., Deschênes M., Matte-Gagné C. Social factors in the development of early executive functioning: a closer look at the caregiving environment. Dev Sci 2012, 15(1):12-24.
37. Bernier A., Carlson S.M., Whipple N. From external regulation to self-regulation: early parenting precursors of young Children's executive functioning. Child Dev 2010, 81(1):326-339.
38. Kraybill J.H., Bell M.A. Infancy predictors of preschool and post-kindergarten executive function. Dev Psychobiol 2012, 10.1002/dev.21057.
39. Seligman M.E.P., Csikszentmihalyi M. Positive psychology: an introduction. Am Psychol 2000, 55(1):5-14.
40. Clark L.A., Watson D., Leeka J. Diurnal variation in the positive affects. Motiv Emot 1989, 13(3):205-234.
41. Cox J., Holden J., Sagovsky R. Detection of postnatal depression. development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry 1987, 150(6):782-786.
42. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23(1):56-62.
43. Watson D., Clark L.A. The PANAS-X: manual for the positive and negative affect schedule-expanded form 1999, University of Iowa, [Report No.: 8-1999].
44. Clark L.A., Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991, 100(3):316-336.
45. Bood S.Å., Archer T., Norlander T. Affective personality in relation to general personality, self-reported stress, coping, and optimism. Individ Differ Res 2004, 2:26-37.
46. Norlander T., Bood S.A.K., Archer T. Performance during stress: affective personality, age, and regularity of physical exercise. Soc Behav Personal 2002, 30(5):495-508.
47. Steptoe A., Wardle J. Positive affect and biological function in everyday life. Neurobiol Aging 2005, 26(1):108-112.
48. Bayley N. Bayley scales of infant and toddler development-third edition: administration manual 2006, Harcourt Assessment, SanAntonio, TX.
49. Kalueff A., Olivier J., Nonkes L., Homberg J. Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 2010, 34(3):373-386.
50. Jacobs B.L., Fornal C.A. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 1999, 21(2):9S-15S.
51. Zheng J., Xu D.F., Li K., Wang H.T., Shen P.C., Lin M., et al. Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons. Int J Clin Exp Pathol 2011, 4(2):162-168.
52. Laine K., Heikkinen T., Ekblad U., Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003, 60(7):720-726.
53. Maciag D., Simpson K.L., Coppinger D., Lu Y., Wang Y., Lin R.C.S., et al. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006, 31(1):47-57.
54. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306(5697):879-881.
55. Gaspar P., Cases O., Maroteaus L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003, 4:1002-1012.
56. Ansorge M.S., Morelli E., Gingrich J.A. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 2008, 28(1):199-207.
57. Hansen H.H., Mikkelsen J.D. Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor. Eur J Pharmacol 1998, 352(2-3):307-315.
58. Gobbi G., Murphy D.L., Lesch K.P., Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 2001, 296(3):987-995.
59. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 2006, 30(2):203-214.
60. Simpson K.L., Weaver K.J., de Villers-Sidani E., Lu J.Y.F., Cai Z., Pang Y., et al. Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci 2011, 108(45):18465-18470.